Skip to main content

Table 4 Subgroup analysis for recurrence-free-survival according to neutrophil–lymphocyte ratio

From: Increased neutrophil–lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification

NLR

n (%)

RFS

Hazard ratio

95% CI

P‒value

Nonfunctional PanNEN

    

 < 2.62

56 (80)

Reference

 

0.002

 ≥ 2.62

14 (20)

4.95

1.30‒20.1

 

Functional PanNEN

    

 < 2.62

47 (94)

Reference

 

0.198

 ≥ 2.62

3 (6)

6.18

0.28‒66.4

 
  1. P-value < 0.05 marked in bold font shows statistical significance